Papers

1

Total Citations

31

H-Index

1

About

Xiaoyan Chu is a leading researcher in drug transport and pharmacokinetics, with a primary focus on understanding the molecular mechanisms of P-glycoprotein (P-gp) and its role in drug disposition. Her key research areas include transporter-mediated drug interactions, in vitro assay development, and the prediction of drug absorption and distribution. Chu's most notable contribution is the development of innovative methodologies for evaluating P-gp–drug interactions, exemplified by her highly cited 2012 study, which compared reconstituted P-glycoprotein in a liposomal system with LLC-MDR1 polarized cell monolayers. This work has been instrumental in advancing the field's ability to predict and mitigate drug-drug interactions, earning 31 citations and serving as a foundational reference for pharmaceutical scientists. Her research has directly impacted the design of safer, more effective therapeutics by providing robust tools for assessing transporter function. Chu's achievements highlight her as a key figure in translational pharmacology, bridging basic transporter biology with clinical drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Determining P-glycoprotein–drug interactions: Evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers
31 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago